Decreased sialic acid content of plasma von Willebrand factor in precapillary pulmonary hypertension

被引:0
|
作者
Lopes, AA
de Souza, BF
Maeda, NY
机构
[1] Fdn Pro Sangue Hemoctr Sao Paulo, Biotechnol Lab, Div Pesquisa, BR-05403000 Sao Paulo, SP, Brazil
[2] Univ Sao Paulo, Sch Med, Inst Heart, Sao Paulo, Brazil
关键词
sialic acid; von Willebrand factor; pulmonary hypertension;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
pulmonary hypertension, defective von Willebrand factor protein (vWF) lacking large multimers is present in circulation. This is associated with evidence of chronic endogenous platelet activation. Since asialo vWF has been shown to promote platelet activation and aggregation, we decided to investigate possible changes in the sialic acid content of plasma VWF in patients with precapillary pulmonary hypertension. vWF-associated sialic acid was measured indirectly as a wheat germ agglutinin-reactive substance (WGA-RS, Western blotting), and directly, as a thiobarbituric acid-reactive substance (TBA-RS, spectrophotometric reading). In the sixteen patients we studied (ages 8-45 yr), circulating vWF concentration was 2.18 times normal (p <0.001). However, patient vWF subunit contained 19% (WGA-RS) to 24% (TBA-RS) less sialic acid than the normal protein (p <0.05 for both determinations). In five patients, vWF-associated sialic acid was below 50% normal. We conclude that circulating vWF is hyposialylated in precapillary pulmonary hypertension and speculate that this might influence its interaction with platelets in vivo in these patients.
引用
收藏
页码:683 / 687
页数:5
相关论文
共 50 条
  • [1] Sialic acid content of von Willebrand factor subunit - A simple method for quantitative estimation
    Maeda, NY
    Bydlowski, SP
    Lopes, AAB
    CLINICA CHIMICA ACTA, 1998, 273 (02) : 209 - 211
  • [2] Characterization of von Willebrand factor in primary pulmonary hypertension
    Collados, MT
    Sandoval, J
    López, S
    Massó, FA
    Páez, A
    Borbolla, JR
    Montaño, LF
    HEART AND VESSELS, 1999, 14 (05) : 246 - 252
  • [3] Characterization of von Willebrand factor in primary pulmonary hypertension
    María T. Collados
    Julio Sandoval
    Sergio López
    Felipe A. Massó
    Araceli Páez
    José R. Borbolla
    Luis F. Montaño
    Heart and Vessels, 1999, 14 : 246 - 252
  • [4] Abnormalities in circulating von Willebrand factor and survival in pulmonary hypertension
    Lopes, AA
    Maeda, NY
    Bydlowski, SP
    AMERICAN JOURNAL OF MEDICINE, 1998, 105 (01): : 21 - 26
  • [5] Characterization of von Willebrand factor in primary pulmonary hypertension.
    Collados, MT
    Sandoval, J
    Masso, FA
    Paez, A
    Borbolla, JR
    Montaño, LF
    BLOOD, 1999, 94 (10) : 95B - 95B
  • [6] Prognostic value of von Willebrand factor concentrations in pulmonary hypertension
    Lopes, AAB
    CHEST, 2000, 118 (04) : 1226 - 1226
  • [7] Content and functional activity of von Willebrand factor in apheresis plasma
    Burnouf, T
    Caron, C
    Burkhardt, T
    Goudemand, J
    VOX SANGUINIS, 2004, 87 (01) : 27 - 33
  • [8] Plasma ADAMTS13 and von Willebrand factor in diagnosis and prediction of prognosis in pulmonary arterial hypertension
    Ahmed, Abdulla
    Ahmed, Salaheldin
    Radegran, Goran
    PULMONARY CIRCULATION, 2021, 11 (04)
  • [9] Plasma von Willebrand factor as a predictor of survival in pulmonary arterial hypertension associated with congenital heart disease
    Lopes, A. A.
    Barreto, A. C.
    Maeda, N. Y.
    Cicero, C.
    Soares, R. P. S.
    Bydlowski, S. P.
    Rich, S.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2011, 44 (12) : 1269 - 1275
  • [10] Severity of precapillary pulmonary hypertension: Predictive factor
    de Barros, J. A.
    Sant'Ana, G.
    Martins, G.
    Madlum, L.
    Scremim, C.
    Petterle, R.
    Escuissato, D.
    Lima, E.
    PULMONOLOGY, 2023, 29 : S25 - S35